The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 clinical trials

Explore recruiting the study will investigate the effect of deferoxamine on the impaired reaction to hypoxia in patients with diabetes mellitus type 1 clinical trials.

Also recruiting in Europe

The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Desferal administration to improve the impaired reaction to hypoxia in diabetes (DESIRED) - A randomised, double-blind, placebo-controlled, cross-over study.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 trials by city

The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Toronto The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Vancouver The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Montreal The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Calgary The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Edmonton The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Ottawa The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Winnipeg The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Quebec City The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Hamilton The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Kitchener The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in London The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Halifax The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in New York The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Los Angeles The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Chicago The Study Will Investigate The Effect Of Deferoxamine On The Impaired Reaction To Hypoxia In Patients With Diabetes Mellitus Type 1 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease